La catena delle opzioni mostra i dati chiave delle opzioni azionarie di MicroSectors FANG Index -3X Inverse Leveraged ETNs due January 8, 2038 a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per MicroSectors FANG Index -3X Inverse Leveraged ETNs due January 8, 2038..

MicroSectors FANG Index -3X Inverse Leveraged ETNs due January 8, 2038 (ARCA:FNGD) Azioni, Catena delle Opzioni

MicroSectors FANG Index -3X Inverse Leveraged ETNs due January 8, 2038

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 200 points on Wednesday.
Following the market opening Wednesday, the Dow traded up 0.46% to 44,442.42 while the NASDAQ gained 0.95% to 20,611.65. The S&amp;P 500 also rose, gaining, 0.60% to 6,262.70.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/short-ideas/25/07/46318208/top-2-tech-stocks-that-may-plunge-this-month">Top 2 Tech Stocks That May Plunge This Month</a>
Leading and Lagging Sectors Communication services shares jumped by 1.6% on Wednesday.
In trading on Wednesday, energy stocks dipped by 0.6%.
Top Headline
U.S. wholesale inventories declined by 0.3% month-over-month to $905.5 billion in May in-line with the preliminary estimate and compared to a 0.1% increase in the previous month.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul class="wp-block-list">
<li>Calidi Biotherapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLDI#NASDAQ">CLDI</a>) shares shot up 242% to $1.1463. The stock's surge comes on the heels of a development in the healthcare sector. Calidi Biotherapeutics has been making headlines for its innovative approaches to cancer treatment.</li>
<li>Shares of SU Group Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SUGP#NASDAQ">SUGP</a>) got a boost, surging 203% to $1.36 after the company was awarded an HK$88.5 million hospital contract.</li>
<li>Evoke Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVOK#NASDAQ">EVOK</a>) shares were also up, gaining 150% to $6.65 after the company announced it received a notice of allowance for the U.S. patent application covering GIMOTI in patients with moderate to severe symptoms of Gastroparesis.</li>
</ul>
Equities Trading DOWN
<ul class="wp-block-list">
<li>Park Ha Biological Technology Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHH#NASDAQ">PHH</a>) shares dropped 53% to $1.4001.</li>
<li>Shares of RxSight, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXST#NASDAQ">RXST</a>) were down 40% to $7.68 after the company cut its 2025 revenue guidance from $160M–$175M to $120M–$130M.</li>
<li>Blue Gold Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGL#NASDAQ">BGL</a>) was down, falling 33% to $36.50.</li>
</ul>
Commodities In commodity news, oil traded down 0.8% to $67.82 while gold traded down 0.1% at $3,315.70.
Silver traded down 0.5% to $36.575 on Wednesday, while copper fell 3% to $5.5145.
Euro zone
European shares were higher today. The eurozone's STOXX 600 rose 0.8%, while Spain's IBEX 35 Index rose 1%. London's FTSE 100 gained 0.1%, Germany's DAX 40 gained 1.4% and France's CAC 40 gained 1.4% during the session.
Asia Pacific Markets
Asian markets closed mostly lower on Wednesday, with Japan's Nikkei gaining 0.33%, Hong Kong's Hang Seng falling 1.06%, China's Shanghai Composite declining 0.13% and India's BSE Sensex falling 0.21%.
Economics
U.S. wholesale inventories declined by 0.3% month-over-month to $905.5 billion in May in-line with the preliminary estimate and compared to a 0.1% increase in the previous month.
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/25/07/46320283/this-microsoft-analyst-turns-bullish-here-are-top-5-upgrades-for-wednesday">This Microsoft Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday</a> </li>
</ul>
Photo via Shutterstock

Earnings

Equities

News

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

CLDI

EVOK

RXST

SUGP

Dow Jumps 200 Points; US Wholesale Inventories Fall 0.3% In May

Stifel analyst Ralph Profiti initiates coverage on Newmont (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEM#NYSE">NEM</a>) with a Buy rating and announces Price Target of $73.

Price Target

Initiation

Analyst Ratings

Stifel Initiates Coverage On Newmont with Buy Rating, Announces Price Target of $73

<a href="https://www.globenewswire.com/Tracker?data=Y8xhIaAzqODKu2iemiaRoq9kdZ7pTZ9Qpuh-hfA5-GYzDUxsBDzFxRqQJd8_A8FYbGu8YCPxKRU7PqquCwymioWn0jDjeIb_Wo4NNFwNf8k=">Richardson Electronics, Ltd.</a> (NASDAQ: RELL) today announced a global technology partner agreement with Pakal Technologies, Inc., a cutting-edge innovator in silicon power semiconductor solutions. Under this agreement, Richardson Electronics will partner with Pakal to supply customers with Pakal's advanced 650V and 1200V silicon-based power switches—delivering breakthrough efficiency to customers worldwide.
Pakal Technologies has developed the groundbreaking IGTO(t) - Insulated Gate Turn-Off Thyristor structure. This is the first new high-voltage silicon power semiconductor to be released since the IGBT was introduced 40 years ago. The IGTO(t) is a direct drop-in upgrade for modern IGBTs. Pakal Technologies' IGTO(t) offers up to 30% lower conduction losses compared to modern IGBTs with high frequency switching and improved thermal performance - and cost-effective silicon pricing. The IGTO(t) is a game-changing component for applications in electric vehicles (EVs), renewable energy systems, welding, solar, ANPC 3-level topology, robotics, induction heating, industrial power conversion, and many others.

RELL

Richardson Electronics Partners With Pakal Technologies To Deliver Advanced 650V And 1200V Silicon-Based Power Switches, Featuring New IGTO(t) Technology

CoreWeave Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWV#NASDAQ">CRWV</a>) shares are on watch Wednesday after the company announced that it became the first AI cloud provider to offer <a href="https://www.benzinga.com/pressreleases/25/07/n46316961/coreweave-becomes-the-first-ai-cloud-provider-to-offer-nvidia-rtx-pro-6000-blackwell-gpu-at-scale">Nvidia RTX Pro 6000 Blackwell GPUs at scale</a>.
What Happened: CoreWeave announced the general availability of Nvidia RTX Pro 6000 Blackwell server edition&nbsp;instances, offering up to 5.6x faster LLM inferencing and 3.5x faster text-to-video generation&nbsp;compared to the prior generation offering.
When combined with CoreWeave&#8217;s <a href="http://benzinga.com/topic/AI">AI</a> cloud platform, the new offering gives customers access to a cheaper alternative to larger GPU clusters for building and scaling AI applications. 
&#8220;CoreWeave is built to move at the speed of innovation, and with the new RTX PRO 6000-based instances, we&#8217;re once again first to bring advanced AI and graphics technology to the cloud,&#8221; said&nbsp;Peter Salanki, co-Founder and chief technology officer of CoreWeave. 
&#8220;This is a major step forward for customers building the future of AI, as it gives them the ability to optimize and scale on GPU instances that are ideal for their applications, and a testament to the speed and reliability of our AI cloud platform.&#8221;
CoreWeave shares are bouncing back Wednesday after trading lower to start the week after the company announced a $9 billion <a href="https://www.benzinga.com/trading-ideas/movers/25/07/46280108/coreweave-core-scientific-shares-move-lower-on-9-billion-all-stock-deal">all-stock deal</a> to acquire Core Scientific. The deal, which&nbsp;is anticipated to close in the fourth quarter, is expected to help CoreWeave verticalize its data center footprint.
<h3 class="wp-block-heading">How To Buy CRWV Stock</h3>
By now you're likely curious about how to participate in the market for CoreWeave &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
CRWV Price Action: <a href="http://benzinga.com/quote/crwv">CoreWeave shares</a> were down 1.01% at $149.82 at the time of publication Wednesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/reiteration/25/07/46306575/why-coreweaves-9-billion-deal-isnt-about-chips">Why CoreWeave&#8217;s $9 Billion Deal Isn&#8217;t About Chips</a></li>
</ul>
Photo: courtesy of CoreWeave.

Movers

CRWV

CoreWeave Stock Is Bouncing Back Wednesday: What's Happening?

Truist Securities analyst John McDonald maintains Wells Fargo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>) with a Buy and raises the price target from $83 to $86.

Truist Securities Maintains Buy on Wells Fargo, Raises Price Target to $86

UBS analyst Curt Woodworth maintains Crown Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCK#NYSE">CCK</a>) with a Buy and raises the price target from $114 to $125.

UBS Maintains Buy on Crown Holdings, Raises Price Target to $125

WIIM

BTCS

BTCS shares are trading lower. The company raised its funding target to $225 million to accelerate Ethereum Accumulation and expand staking operations.

Macro Economic Events

Econ #s

Economics

USA Gasoline Inventories 2.658M Barrel Draw Vs 1.700M Barrel Draw Est.

EIA Weekly Distillates Stocks 0.825M Barrel Draw Vs 0.300M Barrel Draw Est.

Guidewire Software (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWRE#NYSE">GWRE</a>) has outperformed the market over the past 10 years by 3.57% on an annualized basis producing an average annual return of 15.04%. Currently, Guidewire Software has a market capitalization of $19.33 billion. 
Buying $1000 In GWRE: If an investor had bought $1000 of GWRE stock 10 years ago, it would be worth $4,069.82 today based on a price of $230.39 for GWRE at the time of writing.
<h3>Guidewire Software's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752071413_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GWRE

Here's How Much $1000 Invested In Guidewire Software 10 Years Ago Would Be Worth Today

Macro Notification

General

USA Crude Oil Inventories 7.070M Barrel Build Vs 1.700M Barrel Draw Est.

Truist Securities analyst John McDonald maintains U.S. Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USB#NYSE">USB</a>) with a Hold and raises the price target from $48 to $50.

Truist Securities Maintains Hold on U.S. Bancorp, Raises Price Target to $50

BTCS Inc. (Nasdaq:&nbsp;<a href="https://www.globenewswire.com/Tracker?data=KSdF_KaaT7aX9ROWw-VMZ9-ZitTy0OqDSsHx_FsmoQDRQoOT-eoqZSjJHZRsYsfyabLElqbPrK3Olaco6W7QSA==">BTCS</a>) ("BTCS" or the "Company") short for Blockchain Technology Consensus Solutions, a blockchain technology-focused company, today announced a funding target increase to $225 million to accelerate the Company's Ethereum accumulation strategy.
The Company's vertically integrated operations, including solo staking through validator nodes and block building, are central to this approach. These activities not only generate recurring, crypto-native revenue but also enhance long-term value per share by compounding ETH-denominated returns.

Financing

Reported Earlier: BTCS Raises Funding Target To $225M To Accelerate Ethereum Accumulation And Expand Staking Operations

Truist Securities analyst John McDonald maintains PNC Financial Services Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNC#NYSE">PNC</a>) with a Hold and raises the price target from $189 to $198.

Truist Securities Maintains Hold on PNC Financial Services Gr, Raises Price Target to $198

<ul>
<li>Company expands digital asset strategy beyond Bitcoin, including Dogecoin (DOGE), Litecoin (LITE), Solana (SOL), Ripple (XRP), Ether (ETH), USD Coin (USDC)</li>
</ul>
LOS ANGELES, July 9, 2025 /PRNewswire/ -- <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4465166-1&amp;h=3576058154&amp;u=https%3A%2F%2Fwww.thumzupmedia.com%2F&amp;a=Thumzup+Media+Corporation">Thumzup Media Corporation</a>&nbsp;("Thumzup" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TZUP#NASDAQ">TZUP</a>), an emerging leader in crypto asset strategies and a social media branding and programmatic marketing solutions, today announced that its Board of Directors has authorized management to begin to accumulate additional cryptocurrencies, specifically Dogecoin (DOGE), Litecoin (LITE), Solana (SOL), Ripple (XRP), Ether (ETH), USD Coin (USDC).
This initiative builds upon Thumzup's previously disclosed Bitcoin ("BTC") acquisition strategy, which permits the Company to hold up to 90% of its liquid assets in BTC. As of July 8, 2025, Thumzup currently holds 19.106 BTC, with a market value of approximately $2.1 million. The Board's latest resolution gives management the authority to evaluate the potential benefits and requirements of diversifying the Company's digital asset portfolio.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

TZUP

Thumzup Expands Crypto Strategy Beyond Bitcoin, Adds DOGE, LTC, SOL, XRP, ETH, And USDC To Portfolio; Holds 19.106 BTC Worth $2.1M

UBS analyst Cleveland Rueckert maintains Ball (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BALL#NYSE">BALL</a>) with a Neutral and raises the price target from $54 to $60.

BALL

UBS Maintains Neutral on Ball, Raises Price Target to $60

Truist Securities analyst John McDonald maintains JPMorgan Chase (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) with a Hold and raises the price target from $280 to $290.

Truist Securities Maintains Hold on JPMorgan Chase, Raises Price Target to $290

UBS analyst Joshua Spector maintains Air Products (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APD#NYSE">APD</a>) with a Buy and raises the price target from $328 to $344.

UBS Maintains Buy on Air Products, Raises Price Target to $344

Truist Securities analyst John McDonald maintains Citigroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>) with a Buy and raises the price target from $84 to $93.

Truist Securities Maintains Buy on Citigroup, Raises Price Target to $93

Truist Securities analyst John McDonald maintains Bank of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) with a Buy and raises the price target from $51 to $53.

Truist Securities Maintains Buy on Bank of America, Raises Price Target to $53

ZC SP ETN REDEEM 08/01/2038 USD 50 - Se D FNGD

Comments

MicroSectors FANG Index -3X Inverse Leveraged ETNs due January 8, 2038

MicroSectors FANG Index -3X Inverse Leveraged ETNs due January 8, 2038 (FNGD) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO